Award Year / Program / Phase:1985 / SBIR / Phase II
Agency:HHS
Principal Investigator:John C. Cheronis , Director
Award Amount:$500,000.00
Abstract:
This project is intended to develop a protease inhibitor that can be safely administered to patients who have ongoing elastin destruction as a major feature of their disease. such diseases include those in which phagocyte action (inflammation) has occurred in conjunction with connective tissue… More